SR9009 ( also known as Stenabolic ) is an experimental circadian rhytm modulator (RevErb-alpha agonist). SR9009 is said to be attractive as a performance-enhancing agent.
So far, SR9009 has revealed anti-inflammatory properties. The anti-inflammatory effects have been shown in animal models of endometriosis, heart attack, Alzheimer’s disease and some autoimmune diseases. In Alzheimer’s disease model mouse, Stenabolic reversed cognitive deficits. However, it has been not shown whether it has nootropic properties. Since SR9009 suppresses proinflammatory cytokines, it does not come as a surprise that it reduces neuroinflammation and neuropathic pain. Furthermore, it reduces blood glucose levels. however, that may be beneficial in the context of diabetes but not necessarily in healthy rats.
The harmful effects of SR9009 is clearly more pronounced against cancer cells of mice when compared to normal cells (no overt toxicity). For example, an effect suppressing the fat tissue was also shown. Above all, in a study investigating age-depended heart hypertrophy, stenabolic showed beneficial effects. Most importatly, studies hint that SR9009 might be useful for treatment of sleep and anxiety diorders in rodents.
In humans, these properties have not been tested. In addition, there is a fundamental difference between mice and humans. To clarufy, mice are nocturnal animals while humans cannot be considered nocturnal. Currently, it seems a quite promising rodent drug. Likewise the lack of clinical studies implies that the benefits for humans are quite speculative.
-Reduces Blood Cholesterol
-Protects from Heart Disease
-Helps with Anxiety
-Helps Lose Fat
-Promotes Healthier Appetite And Control
Read more about SR9009.